$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Sustained release intraocular implants and methods for preventing retinal dysfunction

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/00
  • A61K-031/498
  • A61P-027/02
출원번호 US-0142083 (2008-06-19)
등록번호 US-8609144 (2013-12-17)
발명자 / 주소
  • Burke, James
  • Hughes, Patrick M.
  • Werhner, Orilla C.
  • Lin, Ton C.
  • Escobar, Maria
  • Huang, Glenn
  • Zhang, Kai-Ming
  • Wheeler, Larry A.
  • Donn, Rosy S.
출원인 / 주소
  • Allergan, Inc.
대리인 / 주소
    Wine, Laura L.
인용정보 피인용 횟수 : 0  인용 특허 : 122

초록

Biocompatible intraocular microspheres and implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic

대표청구항

1. A method for enhancing normal retinal neuronal function in a normal eye, the method comprising the step of intravitreal administration to a normal eye of an ophthalmic composition comprising microspheres comprising a therapeutic component, the therapeutic component consisting of brimonidine freeb

이 특허에 인용된 특허 (122)

  1. Andrews, Steven W.; Wurster, Julie A.; Wang, Edward H.; Malone, Thomas, 3-(Arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors.
  2. Garst Michael E. ; MacDonald Timothy L., Anti-angiogenic agents.
  3. Saunders Richard J. (San Jose CA) Mefferd Wayne Sherman (Los Altos Hills CA), Apparatus for tracking moving workpiece by a laser beam.
  4. Dougherty Thomas J. (Grand Island NY), Bacteriochlorophyll-a derivatives useful in photodynamic therapy.
  5. Dougherty Thomas J. (Grand Island NY), Bacteriochlorophyll-a derivatives useful in photodynamic therapy.
  6. Makovec Francesco (Monza ITX) Rovati Lucio C. (Monza ITX) Rovati Luigi A. (Monza ITX), Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists.
  7. Wong Vernon G., Biocompatible ocular implants.
  8. Wong Vernon G. (Rockville MD) Kochinke Frank (San Jose CA), Biocompatible ocular implants.
  9. Wong Vernon G. ; Kochinke Frank, Biocompatible ocular implants.
  10. Calhoun Jason H. (Galveston TX) Mader Jon T. (Galveston TX), Biodegradable antibiotic implants and methods of their use in treating and preventing infections.
  11. Wong Vernon G. (Rockville MD), Biodegradable ocular implants.
  12. Wong Vernon G. (Rockville MD), Biodegradable ocular implants.
  13. Wong Vernon G. (Sunnyvale CA), Biodegradable ocular implants.
  14. Ogura Yuichiro,JPX ; Ikada Yoshito,JPX, Biodegradable scleral plug.
  15. Dennis Andrew (Merseyside GB2) Timmins Peter (Merseyside GB2) Lee Kevin (Cheshire GB2), Buoyant controlled release powder formulation.
  16. Dreyer, Evan B., Calcium blockers to treat proliferative vitreoretinopathy.
  17. Vernon Wong ; Lin Peng, Composition and method for treating glaucoma.
  18. Sander Thomas W. (Newtown CT) Kaplan Donald S. (Weston CT), Composition for effecting bone repair.
  19. Rork Gerald S. ; Pipkin James D., Controlled release simvastatin delivery device.
  20. Wong Vernon G. ; Hu Mae W. L. ; Berger ; Jr. Donald E., Controlled-release biocompatible ocular drug delivery implant devices and methods.
  21. Ohtori Akira (Iizuka JPX) Andoh Masako (Amagasaki JPX) Morita Yasushi (Toyonaka JPX), Controlled-release pharmaceutical preparation for intra-ocular implant.
  22. Thurlow Heida L. (10814 Riverview Houston TX 77042), Cookware with covers having metal handles.
  23. Woodward David F. (El Toro CA) Andrews Steven W. (Rancho Santa Marguerita CA) Burk Robert M. (Irvine CA) Garst Michael E. (Newport Beach CA), Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents.
  24. Sanders Lynda M. (Palo Alto CA) Domb Abraham (Brookline MA), Delayed/sustained release of macromolecules.
  25. Hearst David Paul ; Cimino George D. ; Hearst John Eugene ; Isaacs Stephen T., Device and method for photoactivation.
  26. Higuchi Takeru (Lawrence KS) Hussain Anwar (Lexington KY), Device consisting of copolymer having acetoxy groups for delivering drugs.
  27. Mizokami Kazunori (Hachioji JPX), Diaphragm control circuit for TTL automatic electronic flash.
  28. Chandraratna Roshantha A. S. (El Toro CA), Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity.
  29. Lee David A. (827 Levering Ave. ; #807 Los Angeles CA 90024), Drug delivery device.
  30. Kaufman Herbert E. (300 Lake Marina Dr. ; Unit 18E New Orleans LA 70124), Drug delivery system.
  31. Shell John W. (Hillsborough CA) Gale Robert M. (Mountain View CA), Drug delivery system for controlled ocular therapy.
  32. Dougherty Thomas J. (Grand Island NY) Potter William R. (Grand Island NY) Weishaupt Kenneth R. (Sloan NY), Drugs comprising porphyrins.
  33. Dougherty Thomas J. (Grand Island NY) Potter William R. (Grand Island NY) Weishaupt Kenneth R. (Sloan NY), Drugs comprising porphyrins.
  34. D\Amato Robert J. (Lancaster PA) Folkman Moses J. (Brookline MA), Estrogenic compounds as anti-angiogenic agents.
  35. Sessler Jonathan L. (Austin TX) Hemmi Gregory W. (Austin TX) Murai Toshiaki (Nagara JPX), Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles.
  36. Wong Vernon G. (10908 Rosemont Dr. Rockville MD 20852), Eye implant for relieving glaucoma, and device and method for use therewith.
  37. Russell Thomas A., Flexible illuminators for phototherapy.
  38. Wong Vernon ; Kochinke Frank, Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents.
  39. Yim Kalvin W. K. (N. andover MA) Huberty Michael C. (Andover MA) Northey ; Jr. Richard P. (Ipswich MA) Schrier Jay A. (Andover MA), Formulations for delivery of osteogenic proteins.
  40. Lipton Stuart A. ; Dreyer Evan B., Glaucoma treatment.
  41. Stuart A. Lipton ; Evan B. Dreyer, Glaucoma treatment.
  42. Brown, J. David, Glaucoma treatment device and method.
  43. Dougherty Thomas J. (Grand Island NY) Potter William R. (Grand Island NY) Weishaupt Kenneth R. (Sloan NY), Hematoporphyrin derivatives and process of preparing.
  44. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  45. Chen James C. ; Wiscombe Brent, Illuminating device for treating eye disease.
  46. Francis Moussy ; Donald Kreutzer ; Diane Burgess ; Jeffrey Koberstein ; Fotios Papadimitrakopoulos ; Samuel Huang, Implant coating for control of tissue/implant interactions.
  47. Olejnik Orest ; Hughes Patrick M. ; Kent John S., Implant device with a retinoid for improved biocompatibility.
  48. Olejnik, Orest; Hughes, Patrick M.; Kent, John S., Implant device with a retinoid for improved biocompatibility.
  49. Orest Olejnik ; Patrick M. Hughes ; John S. Kent, Implant device with a retinoid for improved biocompatibility.
  50. Trauner Kenneth ; Hasan Tayyaba ; Hamblin Michael R., Inhibition of fibrosis by photodynamic therapy.
  51. Bodor Nicolae S. (Lawrence KS) Yuan Sun-Shine (Lawrence KS), Intermediates useful in the synthesis of optically active m-acyloxy-a 상세보기
  • Koch Hans-Reinhard,DEX ITX D-53177, Intraoccular lens arrangement and method for correcting astigmatism.
  • Chan Ming F. (Santa Ana CA) Gluchowski Charles (Mission Viejo CA) Woodward David F. (El Toro CA), Intraocular pressure reducing 9,11-diacyl prostaglandins.
  • Andrews, Steven W.; Hebert, Jonathan J., Kinase inhibitors for the treatment of disease.
  • Torphammar Nils Gustav Yngve (Ostermalmsvagen 6 S-612 00 Finspang SW) Torphammar Per Gustav (Surbrunnsgatan 8 S-411 19 Goteborg SW), Locking mechanism for a safety belt.
  • Montandon Daniel (Yverdon-Les-Bains CHX), Mast for sailboat.
  • Ashton Paul ; Crooks Peter Anthony ; Cynkowski Tadeusz ; Cynkowska Grazyna ; Guo Hone, Means to achieve sustained release of synergistic drugs by conjugation.
  • Shell John W. (Hillsborough CA) Gale Robert M. (Mountain View CA), Medication indicated for ocular hypertension.
  • Glossop Neil David, Method and system to facilitate image guided surgery.
  • Guo Hong ; Ashton Paul, Method for treating and/or preventing retinal diseases with sustained release corticosteroids.
  • Guo, Hong; Ashton, Paul, Method for treating and/or preventing retinal diseases with sustained release corticosteroids.
  • Wen Rong ; Steinberg ; deceased Roy H. ; Lavail Matthew M., Method for treatment of retinal diseases.
  • Klein Elliott S. ; Nagpal Sunil ; Chandraratna Roshantha A., Method of identifying negative hormone and/or antagonist activities.
  • Wheeler Larry A. ; Woldemussie Elizabeth ; Lai Ronald K., Method of using (2-imidazolin-2-ylamino) quinoxoalines in treating neural injury.
  • Evans Ronald M. ; Schulman Ira G., Methods for the detection of ligands for retinoid X receptors.
  • Wong, Vernon G.; Hu, Mae W. L., Methods for treating inflammation-mediated conditions of the eye.
  • Dougherty Thomas J. (Grand Island NY) Potter William R. (Grand Island NY) Weishaupt Kenneth R. (Sloan NY), Methods for treatment of tumors.
  • Richter Anna M.,CAX ; Levy Julia G.,CAX ; Hariton Claude A. A.,CAX ; Huber Gustave,CHX ; Stewart William C. ; Fsadni Mario G.,CHX, Methods, compositions and articles for reducing or preventing the effects of inflammation.
  • Bernstein Howard (Cambridge MA) Zhang Yan (Cambridge MA) Khan M. Amin (Downingtown PA) Tracy Mark A. (Arlington MA), Modulated release from biocompatible polymers.
  • Pelka David G. (Los Angeles CA) Parkyn ; Jr. William A. (Costa Mesa CA), Multiple wavelength light processor.
  • David F. Woodward ; Steven W. Andrews ; Robert M. Burk ; Michael E. Garst, Non-acidic cyclopentane heptanoic acid,2-cycloalkyl or arylalkyl derivatives as therapeutic agents.
  • Arnold Randall K. (San Jose CA), Ocular drug delivery device.
  • Shell John W. (Hillsborough CA) Gale Robert M. (Mountain View CA), Ocular insert housing steroid in two different therapeutic forms.
  • Shell John W. (Hillsborough CA) Gale Robert M. (Mountain View CA), Ocular preparation housing steroid in two different therapeutic forms.
  • Robinson, Michael R.; Csaky, Karl G.; Yuan, Peng; Sung, Cynthia; Nussenblatt, Robert B.; Smith, Janine A., Ocular therapeutic agent delivery devices and methods for making and using such devices.
  • Gale Robert M. (Mt. View CA) Ben-Dor Monique (Palo Alto CA) Keller Nancy (Palo Alto CA), Ocular therapeutic system for dispensing a medication formulation.
  • Higuchi Takeru (Lawrence KS) Hussain Anwar (Lexington KY), Ocular therapeutic system manufactured from copolymer.
  • Higuchi Takeru (Lawrence KS) Hussain Anwar (Lexington KY), Ocular therapeutic system with selected membranes for administering ophthalmic drug.
  • Chang, James; Hughes, Patrick, Oil-in-water method for making alpha-2 agonist polymeric drug delivery systems.
  • Cortese Richard (San Jose CA) Theeuwes Felix (Los Altos CA), Osmotic device with hydrogel driving member.
  • Ayer Atul D. (Mountain View CA) Theeuwes Felix (Los Altos CA), Osmotic system with distribution zone for dispensing beneficial agent.
  • Horlington Michael (Bishops Stortford GB2), Pharmaceutical compositions.
  • Ron Eyal (Lexington MA) Turek Thomas J. (Boston MA) Isaacs Benjamin S. (Tewksbury MA) Patel Himakshi (Tewksbury MA) Kenley Richard A. (Andover MA), Pharmaceutical formulations of osteogenic proteins.
  • Pandey Ravindra K. (Buffalo NY) Dougherty Thomas J. (Grand Island NY), Photosensitizing agents.
  • Pandey Ravindra K. (Buffalo NY) Dougherty Thomas J. (Grand Island NY), Photosensitizing agents.
  • Sinofsky Edward L., Phototherapeutic apparatus with diffusive tip assembly.
  • Meyer Damon L. ; Mallett Robert W., Pretargeting methods and compounds.
  • Theeuwes ; Felix ; Saunders ; Richard J. ; Mefford ; Wayne S., Process for forming outlet passageways in pills using a laser.
  • Ayer Atul D. (Mountain View CA) Theeuwes Felix (Los Altos CA), Process for manufacturing device with dispersion zone.
  • Brine Charles J. (Princeton NJ), Process for polymerizing poly(lactic acid).
  • Horowitz Bernard ; Valinsky Jay E. ; Geacintov Nicholas E. ; Williams Bolanle ; Rywkin Shanti B. ; Nunno Henrietta, Processes for photoreactive inactivation of a virus in blood cell or coagulation factor containing compositions and use thereof for preparing compositions useful for transfusion.
  • Dougherty Thomas J. (Grand Island NY) Pandey Ravindra K. (Buffalo NY), Purified hematoporphyrin dimers and trimers useful in photodynamic therapy.
  • Pandey Ravindra K. (Buffalo NY) Dougherty Thomas J. (Grand Island NY), Pyropheophorbides and their use in photodynamic therapy.
  • Pandey Ravindra K. (Buffalo NY) Dougherty Thomas J. (Grand Island NY), Pyropheophorbides and their use in photodynamic therapy.
  • Pandey Ravindra K. (Buffalo NY) Dougherty Thomas J. (Grand Island NY), Pyropheophorbides conjugates and their use in photodynamic therapy.
  • Zaffaroni Alejandro (Atherton CA), Selective administration of drug with ocular therapeutic system.
  • Buster John L. (Laguna Niguel CA) Ernest Paul H. (Jackson MI), Single stitch suture needle and method.
  • Roser, Bruce J.; Kampinga, Jaap; Colaco, Camilo; Blair, Julian, Solid dose delivery vehicle and methods of making same.
  • Clauss Steven L. (Manville NJ) Pastel Michael J. (Highland Mills NY) Zawadzki Rainer K. (Wuhan CNX), Stable porfimer sodium compositions and methods for their manufacture.
  • Olejnik Orest ; Hughes Patrick M. ; Kent John S., Sterile bioerodible occular implant device with a retinoid for improved biocompatability.
  • Shou Mao Chen TW, Structure for protecting a luggage shell.
  • Gwon Arlene E. (Newport Beach CA) Meadows David (Mission Viejo CA), Subconjunctival implants for ocular drug delivery.
  • Song Tae K. ; Teng Min ; Chandraratna Roshantha A., Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist t.
  • Smith Thomas J. (Boston MA) Ashton Paul (Lexington KY) Pearson Paul A. (Lexington KY), Sustained release drug delivery devices.
  • Bawa Rajan (Fairport NY), Sustained-release formulation containing and amino acid polymer.
  • Klein Elliott S. ; Johnson Alan T. ; Standeven Andrew M. ; Beard Richard L. ; Gillett Samuel J. ; Duong Tien T. ; Nagpal Sunil ; Vuligonda Vidyasagar ; Teng Min ; Chandraratna Roshantha A., Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities.
  • Klein Elliott S. ; Johnson Alan T. ; Standeven Andrew M. ; Beard Richard L. ; Gillett Samuel J. ; Duong Tien T. ; Nagpal Sunil ; Vuligonda Vidyasagar ; Teng Min ; Chandraratna Roshantha A., Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities.
  • Weiner Alan L. (Cranbury NJ) Sinnett Kevin (Mukwonago WI) Johnson Sterling (Skillman NJ), Tack for intraocular drug delivery and method for inserting and removing same.
  • Bommer Jerry C. (Ogden UT) Burnham Bruce F. (Logan UT), Tetrapyrrole therapeutic agents.
  • Bommer Jerry C. (Ogden UT) Burnham Bruce F. (Logan UT), Tetrapyrrole therapeutic agents.
  • Bommer Jerry C. (Ogden UT) Burnham Bruce F. (Logan UT), Tetrapyrrole therapeutic agents.
  • Sessler Jonathan L. (Austin TX) Mody Tarak D. (Sunnyvale CA) Hemmi Gregory W. (Sunnyvale CA) Kral Vladimir A. (Austin TX) Magda Darren (Cupertino CA), Texaphyrin-oligonucleotide conjugates.
  • Yamamori Kaoru (Kawanishi JPX) Komuro Yoshihiro (Nishinomiya JPX) Yamahira Yoshiya (Ibaraki JPX) Noguchi Takeshi (Takatsuki JPX), Treatment of glaucoma or ocular hypertension and ophthalmic composition.
  • Billson Francis Alfred,AUX ; Penfold Philip Leslie,AUX, Treatment of macular degeneration.
  • Abelson Mark B. (26 Phillips St. Andover MA 01810), Treatment of ocular hypertension with class I calcium channel blocking agents.
  • Blumenkranz Mark S. ; Woodburn Kathryn W. ; Miller Richard A. ; Young Stuart W., Use of Texaphyrin in ocular diagnosis and therapy.
  • Gubin Jean (Brussels BEX) Chatelain Pierre (Brussels BEX) Descamps Marcel (Muret FRX) Nisato Dino (Saint Georges D\Orques FRX) Inion Henri (Wemmel BEX) Lucchetti Jean (Chastre BEX) Mahaux Jean-Marie , Use of aminoalkoxyphenyl derivatives for reducing and/or controlling excessive intraocular pressure.
  • Bito Laszlo Z. (New York NY), Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma.
  • Levy Julia,CAX ; Miller Joan W. ; Gradoudas Evangelos S. ; Hasan Tayyaba ; Schmidt-Erfurth Ursula,DEX, Use of green porphyrins to treat neovasculature in the eye.
  • Miller Joan W. ; Gragoudas Evangelos S., Use of green porphyrins to treat neovasculature in the eye.
  • Dougherty Thomas J. (Grand Island NY) Pandey Ravindra K. (Buffalo NY), Use of purified hematoporphyrin trimers in photodynamic therapy.
  • Gombotz Wayne R. (Lexington MA) Healy Michael S. (E. Bridgewater MA) Brown Larry R. (Newton MA), Very low temperature casting of controlled release microspheres.
  • 섹션별 컨텐츠 바로가기

    AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

    AI-Helper 아이콘
    AI-Helper
    안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
    ※ AI-Helper는 부적절한 답변을 할 수 있습니다.

    선택된 텍스트